(Q36619691)

English

CA 125 regression after two completed cycles of chemotherapy: lack of prediction for long-term survival in patients with advanced ovarian cancer.

scientific article published on October 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10574252%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

CA 125 regression after two completed cycles of chemotherapy: lack of prediction for long-term survival in patients with advanced ovarian cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10574252%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Mucin 16, cell surface associated

1 reference

based on heuristic

inferred from title

Andreas Obermair

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10574252%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

Peters-Engl C

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10574252%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Heinzl H

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10574252%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Buxbaum P

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10574252%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sevelda P

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10574252%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Medl M

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10574252%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

0 references

publication date

1 October 1999

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10574252%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10574252%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

81

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10574252%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10574252%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

662-666

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10574252%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

The National Cancer Data Base report on ovarian cancer. American College of Surgeons Commission on Cancer and the American Cancer Society

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362892

30 September 2017

CA 125 half-life in ovarian cancer: a multivariate survival analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362892

30 September 2017

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362892

30 September 2017

Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362892

30 September 2017

The prognostic significance of the half-life of serum CA 125 in patients responding to chemotherapy for epithelial ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362892

28 June 2018

CA 125 as an independent prognostic factor for survival in patients with epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362892

28 June 2018

Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362892

20 September 2018

Assessing time-by-covariate interactions in proportional hazards regression models using cubic spline functions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362892

20 September 2018

Predictive value of CA 125 during early chemotherapy of advanced ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10574252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CA 125 serum levels in the early post-operative period do not reflect tumour reduction obtained by cytoreductive surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/10574252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum CA 125 level allows early identification of nonresponders during induction chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10574252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic value of serum CA 125 in patients with advanced ovarian carcinoma: an analysis of 573 patients by the Medical Research Council Working Party on Gynaecological Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10574252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive factors for long-term survival in patients with advanced ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10574252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ovarian cancer: the prognostic value of the serum half-life of CA125 during induction chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10574252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CA 125 for the monitoring of ovarian carcinoma during primary therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10574252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ovarian carcinoma: a multivariate analysis of prognostic factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/10574252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CA 125 surveillance and second-look laparotomy in ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10574252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of CA-125 to predict survival of patients with ovarian carcinoma. North Thames Cooperative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10574252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epithelial carcinoma of the ovary:prognostic importance of histologic grade

1 reference

https://pubmed.ncbi.nlm.nih.gov/10574252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of CA 125 in advanced ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10574252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreduction

1 reference

https://pubmed.ncbi.nlm.nih.gov/10574252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early serum CA125 response and outcome in epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10574252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690744

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BJC.6690744

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10574252%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10574252%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10574252%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36619691&oldid=2199102609"